James J. Dignam to Estrogen Receptor Modulators
This is a "connection" page, showing publications James J. Dignam has written about Estrogen Receptor Modulators.
Connection Strength
0.251
-
Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst. 2003 Oct 01; 95(19):1467-76.
Score: 0.239
-
Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes. J Natl Cancer Inst. 2001 Jan 17; 93(2):112-20.
Score: 0.012